Jinyu Zhang

Jinyu Zhang

Auto-generated profile, based on publicly available information

Jinyu Zhang

Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2024 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
FSFabian P Suchy
Fabian P Suchy
DKDaiki Karigane
Daiki Karigane
YNYusuke Nakauchi
Yusuke Nakauchi
MHMaimi Higuchi
Maimi Higuchi
JZJinyu Zhang
Jinyu Zhang
HNHiromitsu Nakauchi
Hiromitsu Nakauchi

12 January 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
CCCarsten T. Charlesworth
Carsten T. Charlesworth
SHShota Homma
Shota Homma
FSFabian Suchy
Fabian Suchy
SWSicong Wang
Sicong Wang
JBJoydeep Bhadury
Joydeep Bhadury
HNHiromitsu Nakauchi
Hiromitsu Nakauchi
A multitude of tools now exist that allow us to precisely manipulate the human genome in a myriad of different ways. However, successful delivery of these tools to the cells of human patients remains a major barrier to their clinical implementation. Here we introduce a new cellular approach for in vivo genetic engineering, S ecreted P article I nformation T ransfer (SPIT) that utilizes human cells as delivery vectors for in vivo genetic engineering. We demonstrate the application of SPIT for cell-cell delivery of Cre recombinase and CRISPR-Cas9 enzymes, we show that genetic logic can be incorporated into SPIT and present the first demonstration of human cells as a delivery platform for in vivo genetic engineering in immunocompetent mice. We successfully applied SPIT to genetically modify multiple organs and tissue stem cells in vivo including the liver, spleen, intestines, peripheral blood, and bone marrow. We anticipate that by harnessing the large packaging capacity of a human cell’s nucleus, the ability of human cells to engraft into patients’ long term and the capacity of human cells for complex genetic programming, that SPIT will become a paradigm shifting approach for in vivo genetic engineering.

1 October 2026 in JTCVS Open
Verified
Journal Article
Open access
JZJinyu Zhang
Jinyu Zhang
MBMarek Brzezinski
Marek Brzezinski
HKHashem Kalthoum
Hashem Kalthoum
JKJulia E. Katter
Julia E. Katter
CTCasey Tan
Casey Tan
JKJasleen Kukreja
Jasleen Kukreja